NCT06832566View on ClinicalTrials.gov

Ramadan Fasting Outcomes in Patients With Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension.

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

April 15, 2025

Study Completion Date

April 15, 2025

Conditions
Secondary Adrenal InsufficiencyHypotension
Interventions
DRUG

Fludrocortisone 0.1 Milligrams (mg)

Treatment of hypotension with fludrocortisone 0.05mg/day in patients with secondary adrenal insufficiency before Ramadan fasting. Outcomes (number of fasted days and complications during fasting) will be compared between Ramadan fasting 2025 (with fludrocortisone) and Ramadan 2023 (without fludrocortisone).

Trial Locations (1)

1007

Hopital La Rabta, Tunis

All Listed Sponsors
lead

Hopital La Rabta

OTHER